Corporate News Details

Home | Corporate News Details

The implementation of Roche’s Total Laboratory Automation of Labaid Diagnostics Ltd. (Dhanmondi).

Labaid Diagnostics Ltd. (Dhanmondi) has taken a significant leap forward in diagnostic capabilities with the introduction and inauguration of Roche’s Total Laboratory Automation set-up, seamlessly integrated with state-of-the-art pre-analytical systems. This cutting-edge advancement marks a pivotal moment in enhancing the quality, speed, and efficiency of our laboratory sample processing.

The implementation of Roche’s Total Laboratory Automation, coupled with the latest generation SWA integrated solutions, heralds a new era in diagnostic excellence. By automating key processes from sample intake to analysis, we are poised to deliver unparalleled precision and reliability in our diagnostic services.

This innovative system not only streamlines workflow but also empowers our clinicians with rapid diagnostic decisions. With access to a comprehensive suite of high-value medical biomarkers, clinicians can now make informed decisions with unprecedented speed and accuracy, ultimately enhancing patient care outcomes.

At Labaid Diagnostics, we are committed to leveraging technology to redefine the standards of diagnostic excellence. The introduction of Roche’s Total Laboratory Automation underscores our dedication to providing patients with the highest quality healthcare services while driving efficiency and innovation in the field of diagnostics